Home  >  News
Corporate + Font Resize -

Biocon’s Vishakhapatnam API facility completes US FDA inspection

Our Bureau, Bengaluru
Wednesday, September 20, 2017, 12:10 Hrs  [IST]

Biocon has announced that it successfully cleared the US Food and Drug Administration (FDA) audit for its active pharmaceutical ingredients (API) manufacturing facility in Vishakhapatnam, Andhra Pradesh. The audit was from September 11 to 15, 2017.
 
The facility has completed the audit without any observations. No form 483 was issued. The successful audit of this facility reflects our strong commitment to cGMP compliance at our manufacturing facilities, stated the company spokesperson.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
anbu rahul Oct 19, 2017 4:50 PM
useful to me
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |